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Abstract Misfolded proteins are recognized by the
protein quality control and eventually degraded by the
ubiquitin-proteasome system. Previously, we demonstrated
accumulation of a misfolded non-glycosylated protein,
namely proinsulin, in enlarged pre-Golgi intermediates and
dilated rough endoplasmic reticulum (ER) domains in
pancreatic b-cells of Akita mice. In order to exclude effects
possibly due to coexisting wild type and mutant proinsulin
in pancreatic b-cells, CHO cells expressing singly wild type
or mutant C96Y proinsulin 2 were now analyzed by electron
microscopic morphometry and immunogold labeling as
well as serial section 3D analysis. We found a significant
increase in volume density of pre-Golgi intermediates in
CHO Ins2C96Y cells which was principally due to an
increase of its tubular elements, and no significant changes
of the ER. The average diameter of the pre-Golgi inter-
mediates of CHO Ins2C96Y cells was about twice that of
CHO Ins2wt cells. The enlarged pre-Golgi intermediates and
the ER of CHO Ins2C96Y cells were positive for proinsulin,
which was not detectable in the significantly enlarged Golgi
cisternal stack. Treatment of CHO Ins2C96Y cells with
proteasome inhibitors resulted in the formation of proin-
sulin-containing aggresomes. We conclude that misfolded
proinsulin causes enlargement of pre-Golgi intermediates
which indicates their involvement in protein quality control.
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Introduction
During synthesis and subsequent traffic, proteins are sur-
veyed by a system of quality control which monitors their
folding and assembly state and eliminates faulty products
(Ellgaard and Helenius 2003; Meusser et al. 2005; Roth
2002; Sitia and Braakman 2003). It is noteworthy that fold-
ing of de novo synthesized proteins, despite the assistance of
chaperones, is an inefficient process yielding often <50%
mature proteins suited for transport beyond the endoplasmic
reticulum (ER) (Lukacs et al. 1994; Peta¨ja¨-Repo et al. 2000;
Ward and Kopito 1994). Nonetheless, the high rate of protein
waste production appears not to be harmful to cells. The
situation strikingly changes when proteins permanently fail
to fold due to mutations or chronic stress. In fact, many
congenital diseases have been recognized to be due to protein
misfolding (Aridor and Hannan 2002; Barral et al. 2004; Kim
and Arvan 1998). However, morphological signs of cellular
indigestion and of cell injury may be variable in the various
protein folding diseases. The ER and the pre-Golgi inter-
mediates can appear structurally unaltered when misfolded
proteins are efficiently degraded by the proteasome (Hirano
et al. 2003; Naim et al. 1988; Tamarappoo and Verkman
1998; Yam et al. 2006). On the other hand, accumulation of
misfolded proteins may cause distention of ER cisternae and
enlargement of pre-Golgi intermediates (Gilbert et al. 1998;
MedeirosNeto et al. 1996; Raposo et al. 1995; Zuber et al.
2004). Different types of inclusion bodies represent other
structural hallmarks of protein folding diseases. For instance,
Russell bodies, which are distended parts of ER, arise from
the accumulation of insoluble aggregates of misfolded pro-
teins (Alanen et al. 1985; Kopito and Sitia 2000; Mattioli
et al. 2006; Valetti et al. 1991; Yam et al. 2007). On the other
hand, aggresomes represent pericentriolar cytosolic accu-
mulations of aggregated proteins, which form when the
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digestive capacity of the proteasome is exceeded or its pro-
teolytic activity is experimentally inhibited (Fabunmi et al.
2000; Garcia-Mata et al. 2002; Johnston et al. 1998; Kopito
and Sitia 2000; McNaught et al. 2002; Wigley et al. 1999;
Wojcik et al. 1996; Zatloukal et al. 2002).
Akita mice represents an animal model for type 2 dia-
betes (Kayo and Koizumi 1998; Yoshioka et al. 1997). The
animals are heterozygous for a missense mutation in the
insulin 2 gene that substitutes tyrosine for cystein at posi-
tion 96 and disrupts one of the two disulfide bounds
between the A and B chain of proinsulin (Wang et al. 1999).
The mutant, non-convertable proinsulin (Ins2C96Y) in pan-
creatic b-cells, as well as in transfected CHO cells, has been
shown to accumulate intracellularly as dimers or higher
molecular mass forms, to cause overexpression of BiP and
PDI, and to form complexes with BiP (Oyadomari et al.
2002b; Wang et al. 1999). Although the mutant Ins2C96Y
becomes degraded by the ubiquitin-proteasome pathway, it
also induced ER stress markers and components of the ER-
associated protein degradation (ERAD) (Allen et al. 2004).
ER stress, therefore, is a major pathogenetic factor in b-cell
apoptosis (Harding and Ron 2002; Oyadomari et al. 2002a)
and has been shown to be causative for the development of
diabetes in Akita mice (Oyadomari et al. 2002b).
Our previous analysis by electron microscopic mor-
phometry, serial section analysis, and immunoelectron
microscopy of pancreatic b-cells of Akita mice demon-
strated accumulation of proinsulin mainly in expanded pre-
Golgi intermediates and to a lesser extent in dilated ER
subdomains (Zuber et al. 2004). A prominent feature of the
expanded pre-Golgi intermediates were tubules with an
average diameter of 102 nm and a length of up to 500 nm.
Tubules of the same dimensions existed in the pre-Golgi
intermediates of b-cells of control mice (Fan et al. 2003).
However, their number was significantly increased in Akita
mice b-cells. These studies have provided insight into the
cellular and molecular pathology of this animal model of a
protein folding disease.
In the present study, CHO cells stably expressing singly
wild type proinsulin 2 (Ins2wt) or mutant Ins2C96Y were
investigated. We analyzed the early secretory pathway of
the transfected CHO cells by electron microscopic mor-
phometry, 3D reconstruction from serial ultrathin sections
and immunogold electron microscopy. Furthermore, the
effect of proteasome inhibition was analyzed.
Materials and methods
Reagents
Mouse monoclonal anti-human proinsulin antibodies were
a gift of Dr. O. Madsen (Madsen et al. 1984), mouse
monoclonal anti-ERGIC-53 (clone G1/93) antibodies a gift
of Dr. H.-P. Hauri (Schweizer et al. 1988) and rabbit anti-
b COP antibodies were kindly provided by Dr. R. Pep-
perkok (Pepperkok et al. 1993). Guinea pig anti-rat
C-peptide antibody was purchased from Linco Research
Inc., St. Charles, MI, USA, affinity-purified rabbit anti-
mouse IgG, goat anti-mouse IgG and goat anti-rabbit IgG
antibodies as well as RedX-conjugated Fab goat anti-
mouse IgG from Jackson ImmunoResearch Laboratories
Inc., West Grove, PA, USA, and Alexa488-conjugated
goat anti-guinea pig IgG from Invitrogen, Carlsbad, CA,
USA. Staphylococcal protein A (Pharmacia, Kalamazoo,
MI, USA) was complexed with 8 nm gold particles (Roth
et al. 1978) and affinity-purified secondary antibodies with
6 or 12 nm gold particles (Lucocq and Baschong 1986).
Lactacystin was purchased from Sigma, Buchs, Switzer-
land, MG 132 from Calbiochem, VWR, Dietikon, Swit-
zerland, and low melting Agar from FMC Bioproducts,
Rockland, ME, USA. CHO cells stably expressing wild
type (clone w22) or mutant Ins2C96Y (clone a7) were
kindly provided by Dr. T. Izumi (Wang et al. 1999). The
cells were cultured in F12 medium supplemented with
10% fetal calf serum.
Electron microscopic morphometry
Monolayer cultures of CHO cells were fixed in situ with a
mixture of 2% paraformaldehyde and 0.1% glutaraldehyde
in PBS (10 mM phosphate buffer, pH 7.4, and 0.15 M
NaCl) for 30 min at initially 37C, and post-fixed with 1%
aqueous OsO4 for 1 h at ambient temperature. Cells were
removed with a rubber policeman, sedimented by centri-
fugation, enclosed in 2% low melting Agarose and
embedded in Epon according to standard protocol. In order
to study the effect of proteasome inhibition, cell cultures
were grown in the presence of lactacystin (50 lM) for 2
and 4 h or MG 132 (20 lM) for 6 h and fixed as described
above followed by Epon embedding.
For each CHO cell line, thin sections (70 nm nominal
thickness) were cut from three different blocks and 20
photographs each were taken at an original magnification
of ·8,000. Negatives were scanned using Adobe Photo-
shop software and enlarged to a final magnification of
·27,700. Measurement of organelle volume density (Vv)
and numerical density on area (NA, which is the number of
profiles per unit area of reference structure) were carried
out by using the point counting method (Weibel 1979). For
the point counting, the digitized electron micrographs were
overlaid with a grid having a line spacing of 1.73 cm
corresponding to 0.62 lm on the electron micrograph.
Since the reference area, the cytoplasm, varied from pho-
tograph to photograph, the weighted average of VV and NA
had to be calculated. The following equations were used to
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calculate the average (M) and the square of standard
deviation (SD2).
M =
P
XiP
Pi
;
and
SD2 ¼ n
2
n  1ð Þ PPi
 2

X
X2i þ M
X
P2i  2M
X
PiXi
n o
:
Xi: points over the structure of interest; Pi: points over the
reference area (cytoplasm); n: number of photographs
evaluated. For statistical analysis, the t-test was used when
applicable.
The dimensions of the pre-Golgi intermediates were
estimated on series of consecutive thin sections. For this,
each photographical negative from the respective series of
sections was scanned and a drawing of its membrane
contours was made manually. All drawings were posi-
tioned and overlayed and the dimension of the pre-Golgi
intermediates were estimated. Among the serial sections,
the largest profile of a pre-Golgi intermediate was deter-
mined and its maximum and minimum diameter measured.
Their average was taken to represent the dimension of the
pre-Golgi intermediate.
Immunofluorescence
Cells grown on coverslips were fixed with 3% formalde-
hyde in Hanks balanced salt solution for 30 min at initially
37C, rinsed with PBS, amidinated with 50 mM NH4Cl in
PBS and permeabilized with 0.15% saponin in PBS con-
taining 1% BSA for 15 min. Afterwards, they were
simultaneously incubated with mouse monoclonal anti-
ERGIC-53 and guinea pig anti-C-peptide antibodies di-
luted with 0.5% saponin in PBS containing 0.1% BSA for
2 h at ambient temperature, rinsed with PBS containing
0.1% BSA and simultaneously incubated with RedX-con-
jugated Fab goat anti-mouse IgG and Alexa488-conjugated
goat anti-guinea pig IgG antibodies diluted with PBS
containing 0.1% BSA for 1 h at ambient temperature. After
Moviol embedding, cover slips were inspected by epiflu-
orescence using a Zeiss Axioplan microscope equipped
with a digital camera (Axiocam, Zeiss, Oberkochen, Ger-
many). Pictures were acquired using a ·63 (1.4) objective.
Immunoelectron microscopy
For immunogold labeling of ultrathin frozen sections,
monolayer CHO cell cultures were fixed in 2% parafor-
maldehyde and 0.1% glutaraldehyde for 30 min at initially
37C, washed with several changes of PBS, immersed with
PBS containing 50 mM NH4Cl for 30 min and stored in
PBS. Cells were mechanically removed with a rubber
policeman, pelleted by centrifugation and enclosed in 2%
low melting Agarose. Small pieces of Agarose containing
the cells were immersed in 2 M sucrose containing 15%
polyvinol pyrrolidone (10 kD), mounted on aluminum pins,
frozen and stored in liquid nitrogen. Frozen ultrathin sec-
tions were prepared according to Tokuyasu (1978, 1980b)
using a Reichert Ultracut S ultramicrotome equipped with a
Reichert FCS cryochamber, picked up on nickel grids and
stored overnight on gelatin at 4C. Prior to immunolabeling,
gelatin was liquefied at 37C, the grids removed and washed
by floating them on droplets of PBS. For immunolabeling,
grids with the attached thin frozen sections were condi-
tioned on droplets of PBS containing 1% milk and 0.01%
Triton X-100 for 10 min at ambient temperature. Grids
were then transferred to droplets of diluted monoclonal anti-
proinsulin antibody for 14 h at 4C, rinsed on droplets of
distilled water, incubated with affinity-purified rabbit anti-
mouse IgG antibodies (10 lg/ml, 1 h, and ambient tem-
perature) followed by rinses and 8 nm protein A-gold
(OD525 nm = 0.06) for 1 h at ambient temperature (Roth
et al. 1978). Finally, grids were rinsed in PBS, fixed with
2% glutaraldehyde in PBS for 10-20 min, rinsed with PBS
and distilled water, and embedded and stained with meth-
ylcellulose and uranyl acetate according to Tokuyasu (1978,
1980a). For double immunogold labeling, sections were
simultaneously incubated with diluted mouse monoclonal
anti-proinsulin antibodies and rabbit anti-b COP antibodies
Table 1 Morphometric evaluation of endoplasmic reticulum, pre-
Golgi intermediates, and Golgi apparatus in CHO Ins2 cells
CHO Ins2wt CHO Ins2C96Y C96Y/wt P
RER, N 2.70 ± 0.02a 1.76 ± 0.02a 0.65 <0.01
RER, D 0.18 ± 0.08 0.23 ± 0.08 1.28 –
pGI-P 0.21 ± 0.09 2.14 ± 0.26 10.20 <0.001
pGI-G 1.10 ± 0.20 3.10 ± 0.31 2.82 <0.001
pGI-T 0.39 ± 0.92 4.07 ± 2.84 10.44 <0.001
pGI-VT 0.91 ± 1.40 1.25 ± 1.54 1.37 –
Golgi 0.68 ± 1.21 2.00 ± 1.87 2.94 <0.001
Mit 4.78 ± 3.16 4.95 ± 2.89 1.04 –
Based on the evaluation of randomly taken photographs from 20 cells
each from three different Epon blocks, for details see Materials and
methods
RER, N rough endoplasmic reticulum, RER, D dilated rough endo-
plasmic reticulum, pGI-G Golgi associated pre-Golgi intermediates,
pGI-P not Golgi associated pre-Golgi intermediates, pGI-T tubular
regions of pre-Golgi intermediates, pGI-VT vesicular tubular regions
of pre-Golgi intermediates, Mit mitochondria
a Mean ± SE · 10–2 of volume density
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followed by rinses and simultaneous incubation with 6 nm
goat anti-mouse IgG and 12 nm goat anti-rabbit IgG.
Epon ultrathin sections from aldehyde-OsO4 fixed cells
were mounted on nickel grids, placed on droplets of freshly
prepared 1% aqueous periodic acid for 8 min at ambient
temperature (Roth et al. 2000) and rinsed by passing them
over a series of droplets of distilled water. Sections were
conditioned with PBS containing 1% BSA, 0.01% Triton
X-100 and 0.01% Tween 20 and transferred to guinea pig
anti-rat C-peptide antibodies (250-fold diluted) for 2 h.
Fig. 1 Series of consecutive ultrathin sections from CHO Ins2wt
cells. The spatial relationship between transitional elements of the
rough ER (arrowheads) and their budding profiles, Golgi-associated
pre-Golgi intermediates (asterisks), and Golgi apparatus cisternal
stacks (G) can be only fully appreciated upon serial section analysis.
Obviously, several transitional elements of rough ER and pre-Golgi
intermediates are associated with a single Golgi cisternal stack.
Furthermore, a single ER cisterna can form two exit sites with
budding profiles for two distinct Golgi cisternal stacks (arrow in
sections 6–9). M mitochondrium (magnification ·30,500)
164 Histochem Cell Biol (2007) 128:161–173
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Following rinses with buffer, grids were incubated with
8 nm protein A-gold complexes for 1 h. Finally, thin sec-
tions were contrasted with uranyl and lead acetate.
Results
Expression of mutant Ins2C96Y in CHO cells affects
the structure of pre-Golgi intermediates but not of the ER
The CHO cell lines analyzed here have been studied
previously with regard to the secretion of proinsulin 2
(Wang et al. 1999). Although CHO Ins2wt cells were
reported to contain and secrete proinsulin, the mutant
Ins2C96Y proinsulin was found to accumulate intracellu-
larly. In the present study, we found that the volume
density of the rough ER was significantly decreased in
CHO Ins2C96Y cells as compared to CHO Ins2wt cells
(Table 1). However, no significant difference was detected
in regard to dilated portions of the rough ER due to the
large variation (Table 1). In CHO Ins2wt or CHO Ins2C96Y
cells, the pre-Golgi intermediates associated with the
Golgi apparatus or in the periphery of the cells consisted
of transitional elements of the rough ER and of associated
vesiculo-tubular clusters as deduced from the analysis of
series of consecutive ultrathin sections (Figs. 1, 2, 3, 4).
Their structural organization corresponded basically to the
one reported for other cell types (Bannykh and Balch
1997; Fan et al. 2003; Farquhar and Hauri 1997; Hauri
et al. 2000; Palade 1975; Saraste and Svensson 1991;
Zuber et al. 2004). Although the vesiculo-tubular clusters
could be followed through more than ten serial sections,
particularly in CHO Ins2C96Y cells, the budding zone of
the transitional ER was only observed in one or two
sections. Furthermore, a single cisterna of the rough ER
could exhibit two separate budding zones feeding into
distinct cisternal stacks (Fig. 1). In CHO Ins2wt cells, the
tubular structures had an average diameter of 36 nm
(range 12–84 nm) and in CHO Ins2C96Y cells of 46 nm
(range 20–88 nm). As observed previously for pancreatic
b-cells of Akita and control mice (Fan et al. 2003; Zuber
et al. 2004), the tubules in CHO Ins2wt and in CHO
Ins2C96Y cells were always closely related but discrete
from transitional elements of the rough ER (Figs. 1, 2).
The comparative analysis of the volume density of pre-
Golgi intermediates revealed striking differences with a
significant increase in CHO Ins2C96Y cells (Table 1;
Figs. 3, 4). The volume density of Golgi-associated pre-
Golgi intermediates was approximately threefold in-
creased and that of peripheral pre-Golgi intermediates
about tenfold. The average diameter of both Golgi-asso-
ciated and peripheral pre-Golgi intermediates was twofold
increased in CHO Ins2C96Y cells (Table 2). A detailed
analysis furthermore demonstrated that the increase in
Fig. 2 Serial section analysis of
a peripheral pre-Golgi
intermediate in CHO Ins2wt
cells. The transitional element
of the rough ER is marked by an
arrowhead and the vesiculo-
tubular cluster by a broken line.
The arrow in section 4 points to
a budding profile. cv clathrin-
coated vesicle (magnification
·45,000)
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volume density of pre-Golgi intermediates was due to
tubules (Table 1). As already estimated for pancreatic
b-cells of Akita mice (Zuber et al. 2004), an about
threefold increase in volume density of the Golgi appa-
ratus of CHO Ins2C96Y cells was found (Table 1). On the
average, the cisternal stack of CHO Ins2C96Y cell Golgi
apparatus contained 1–2 additional cisternae as compared
to CHO Ins2wt cells (Table 3). However, the profile area
Fig. 3 Series of 15 consecutive ultrathin sections out of 24 serial
sections from CHO Ins2C96Y cells showing a Golgi-associated pre-
Golgi intermediate (asterisks). The numerous tubules are obvious.
Arrowheads: transitional element of rough ER. G Golgi apparatus, N
nucleus, AP1, AP2 autophagosomes (magnification ·33,500)
166 Histochem Cell Biol (2007) 128:161–173
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Fig. 4 Series of 14 consecutive ultrathin sections out of 24 serial
sections from CHO Ins2C96Y cells showing two peripheral pre-Golgi
intermediates (asterisks). Note the abundant tubules and the
pleomorphic structure exhibiting numerous budding profiles (sections
7 and 8). N nucleus (magnification ·30,000)
Histochem Cell Biol (2007) 128:161–173 167
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of the entire stack and that of the first and of the second
cis Golgi apparatus cisternae were the same in CHO
Ins2wt and CHO Ins2C96Y cells (Table 3). The volume
density of mitochondria was not different between CHO
Ins2wt and CHO Ins2C96Y cells (Table 1).
Distribution of Ins2 in CHO cells
By double immunofluorescence, proinsulin in CHO
Ins2C96Y cells was detectable in the nuclear envelope,
throughout the ER and in ERGIC-53 positive structures
(Fig. 5). By immunogold labeling of ultrathin frozen sec-
tions of the human adenocarcinoma cell line Caco-2, the
monoclonal anti-ERGIC-53 antibody was originally de-
scribed to label a tubulovesicular compartment near the cis
side of the Golgi apparatus, including the first cis-cisterna
itself (Schweizer et al. 1988). In ultrathin frozen sections
prepared from CHO Ins2C96Y cells, immunogold labeling
for proinsulin was observed over the nuclear envelope,
throughout the ER and in the pre-Golgi intermediates (alias
ERGIC-53), whereas the Golgi apparatus cisternal stack
was consistently unlabeled (Fig. 6). Proinsulin immuno-
labeling was not detectable in non-transfected cells or
when the monoclonal proinsulin antibody was omitted (not
shown). In CHO Ins2wt cells, only negligible labeling for
proinsulin was detectable (not shown), which would be in
agreement with the biochemical data on its rapid secretion
(Wang et al. 1999). Although by double immunogold
Table 2 Dimension of pre-Golgi intermediates in CHO Ins2 cells
Numbers CHO Ins2wt CHO Ins2C96Y
DMA
(lm)
DMI
(lm)
DAV (lm) DMA
(lm)
DMI
(lm)
DAV (lm)
1 1.0 0.6 0.8 2.4 1.5 2.0
2 1.0 0.9 1.0 1.5 1.0 1.3
3 0.8 0.3 0.6 2.4 1.3 1.9
4 0.9 0.4 0.7 1.0 1.0 1.0
5 0.8 0.5 0.7 1.0 0.8 0.9
6 1.0 1.0 1.0 2.6 1.6 2.1a
7 0.5 0.3 0.4a 0.7 0.6 0.7a
8 0.6 0.2 0.4a 1.9 1.5 1.7a
9 0.6 0.4 0.5a 1.0 0.9 1.0a
10 1.1 0.8 0.9a 1.7 1.0 1.4a
Mean ± SE
of DAV
0.7 ± 0.06 1.40 ± 0.16
Based on the evaluation of series of consecutive ultrathin sections
DMA maximal diameter, DMI minimal diameter, DAV average diameter
a Not Golgi associated pre-Golgi intermediates
Table 3 Morphometric evaluation of the Golgi apparatus in CHO Ins2 cells
CHO Ins2wt CHO Ins2C96Y P
Number of cisternae per stack 5.050 ± 1.234 6.650 ± 2.477 <0.01
Profile area of cisternal stack 0.112 ± 0.031a 0.139 ± 0.083a –
Profile area of first cis cisterna 0.011 ± 0.005a 0.014 ± 0.006a –
Profile area of second cis cisterna 0.013 ± 0.007a 0.015 ± 0.005a –
Based on the evaluation of 30 Golgi apparatus
a Mean ± SE in lm2
Fig. 5 Double immunofluorescence for proinsulin and ERGIC-53,
CHO Ins2C96Y cells. a Proinsulin immunoreactivity as detected with
the anti-C-peptide antibody is observed in nuclear envelope,
throughout the ER and ERGIC-53 positive perinuclear structures. b
ERGIC-53 immunofluorescence exhibites the typical perinuclear
pattern. c In the overlay, proinsulin and ERGIC-53 labeling overlap
(magnification ·1,000)
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labeling, proinsulin and b-COP were both present in
pre-Golgi intermediates, no colocalization was observed
(Fig. 7). Immunogold labeling for b-COP in different cell
types has shown a rather wide distribution including the
ER-Golgi boundary, Golgi cisternal buds and vesicles at
the lateral rims as well as membrane of the trans-Golgi
network (Griffiths et al. 1995; Orci et al. 1994).
Proteasome inhibition causes aggresome formation
in Ins2 expressing CHO cells
For proteasome inhibition, cells were grown in the
presence of lactacystin or MG 132. This short time
exposure to the proteasome inhibitors resulted in the
formation of pericentriolar located highly electron dense
clumps (aggresomes) in CHO Ins2C96Y cells which were
surrounded by intermediate filaments most probably
representing vimentin fibers (Fig. 8). The electron dense
material was reactive with an anti- C-peptide antibody
when ultrathin sections of Epon embedded cells that had
been subjected to antigen retrieval were investigated
(Fig. 8b).
Discussion
In continuation of our previous analysis of pancreatic
b-cells in Akita mice (Fan et al. 2003; Zuber et al. 2004),
we have studied CHO cells expressing singly either Ins2wt
or Ins2C96Y. The most striking change was the significantly
increased volume density of the pre-Golgi intermediates in
CHO Ins2C96Y cells, which was principally due an increase
of its tubular elements. The enlarged pre-Golgi interme-
diates and the ER of CHO Ins2C96Y cells were positive for
proinsulin, which was not detectable in the Golgi cisternal
stack. Treatment of CHO Ins2C96Y cells with proteasome
inhibitors resulted in the formation of typical aggresomes.
Fig. 6 Ultrathin frozen sections from CHO Ins2C96Y cells, immuno-
gold labeling for proinsulin. a, b Gold particles are present over the
ER and Golgi-associated pre-Golgi intermediates (pGI). The Golgi
apparatus cisternal stack (G) does not exhibit immunolabeling
(magnification ·69,000 a, ·88,000 b)
Fig. 7 Ultrathin frozen sections from CHO Ins2C96Y cells, double
immunogold labeling for proinsulin and b-COP. Immunogold
labeling for proinsulin (small gold particles) and b-COP (large gold
particles) is detected over different structures (magnification
·70,000)
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In contrast to pancreatic b-cells in Akita mice which
simultaneously synthesize wild type insulin 1 and 2 and
mutant C96Y proinsulin 2, CHO Ins2C96Y cells exhibit
somewhat different ultrastructural changes. Although the
volume density of narrow rough ER was decreased in both
Akita b-cells and transfected CHO cells, the dilated rough
ER was not significantly increased in CHO Ins2C96Y cells.
This probably is related to the efficient ubiquitination and
proteasomal degradation of Ins2C96Y as observed in trans-
fected COS7 cells (Allen et al. 2004). Treatment of COS7
Ins2C96Y cells with the proteasome inhibitor MG 132 re-
sulted in increased steady state levels of mutant insulin and
this was influenced by HRD1-mediated ubiquitination. The
data obtained on Ins2C96Y-expressing COS7 cells suggest
that the mutant insulin 2 becomes efficiently degraded in a
proteasome-dependent manner. This is also supported by
our electron microscopic analysis of CHO Ins2C96Y cells in
which the formation of proinsulin-reactive aggresomes
could be observed following inhibition of proteasomes by
MG 132 or lactacystin. We also observed the formation of
aggresomes in CHO Ins2wt cells, but they were smaller and
less numerous. If this is related to the missing conversion
of wild type proinsulin to insulin in transfected CHO cells
(Wang et al. 1999) remains to be elucidated. In this con-
text, it is interesting to note that the fate of mutant, non-
convertable proinsulin seems to depend on the cell type it is
expressed. A non-convertable proinsulinR32G/K64T was
sorted and secreted as efficiently as wild type proinsulin in
primary rat pancreatic b-cells (Halban and Irminger 2003).
Nonetheless, as shown in pulse-chase experiments, initially
about 20% of the mutant proinsulin was proteasomally
degraded which is indicative of its recognition by the
protein quality control.
The present observations confirm and extend our pre-
vious ones on pancreatic b-cells of Akita mice (Zuber et al.
2004) that mutant Ins2C96Y accumulates in enlarged pre-
Golgi intermediates. In both pancreatic b-cells and in
transfected CHO cells, it was the tubular elements which
caused their enlarged dimensions and higher volume den-
sity. Although the average diameter of pre-Golgi interme-
diates of Akita mice pancreatic b-cells (0.67 ± 0.04 lm)
and transfected CHO cells (1.40 ± 0.16 lm) was different,
in both cell types there dimensions were about twofold
enlarged as compared to the controls. In view of the present
data, the dimensional change of the pre-Golgi intermedi-
ates appears to be primarily due to mutant InsC96Y. The
reason for the higher increase of volume density of
peripheral pre-Golgi intermediates as compared to Golgi-
associated ones in CHO Ins2C96Y cells, which actually
reflects an numerical increase, remains enigmatic. Taken
together, the entry and/or accumulation of misfolded pro-
teins seems to affect the structural organization of the pre-
Golgi intermediates (Gilbert et al. 1998; Hsu et al. 1991;
Moolenaar et al. 1997; Raposo et al. 1995; Schweizer et al.
1990; Vanslyke et al. 2000).
We also observed a significant increase of volume
density of the Golgi apparatus in the presence of Ins2C967Y
(Zuber et al. 2004 and present study). We can now exclude
Fig. 8 CHO Ins2C96Y cells treated with lactacystin for 4 h. a Peri-
centriolar clumps of electron dense material partially surrounded by a
bundle intermediate filaments are obvious (arrowheads). b Enlarge-
ment of the marked field in a. The electron dense material is labeled
with an antibody directed against C-peptide (magnification ·24,000
a, ·73,000 b)
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that this might be related to coexistence of wild type
insulin 1 and 2 and of mutant proinsulin. Singly Ins2C96Y
expressing CHO cells showed a similar threefold increase
in Golgi apparatus volume density as did Akita mice
pancreatic b-cells. However, proinsulin was undetectable
in the Golgi cisternal stack of transfected CHO cells. If this
reflects absence of proinsulin or is indication of its fast
entry and retrograde transport to the ER remains to be
solved. It has been proposed that misfolded proteins
in order to become eventually degraded will undergo
COPII-mediated transport to the Golgi apparatus and sub-
sequent retrieval via retrograde transport (Caldwell et al.
2001; Vashist et al. 2001; Vashist and Ng 2004).
The possible involvement of the induced tubules of the
pre-Golgi intermediates in the retrotranslocation of proin-
sulinC96Y cannot be answered by the present study. In
contrast to the many details known about the ERAD of
misfolded glycoproteins, rather little is known about the
degradation of misfolded non-glycosylated proteins
(Carvalho et al. 2006; Denic et al. 2006; Ismail and Ng
2006). The misfolded Hong Kong variant of a1-antitrypsin,
which is detectable in both the ER and the pre-Golgi
intermediates (Torossi et al. 2006), has been shown to exit
the ER via EDEM1-positive vesicles (Zuber et al. 2007).
This novel vesicular transport pathway from the ER,
however, does not involve transitional ER and vesiculo-
tubular clusters of pre-Golgi intermediates.
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